Table 4. Surveillance Schedule (First 5 Years) [9-11]
Clinical Stage |
Item |
Recommendations |
Total Number |
In Situ |
Dermatology visits |
Q 6 mo x 3 y, Q 12 mo x 2 y |
8 |
IA = T1a |
CMP, LDH |
Each visit |
6 |
CXR |
optional, to address symptoms |
0 |
|
Oncology visits |
Q 6 mo x 1 y , Q12mo x 4 y |
6 |
|
Dermatology visits |
Q 4 mo x 1 y, Q 6 mo x 2 y, Q 12 mo x 2 y |
9 |
|
IB = T1b and T2a |
CMP LDH |
Each visit |
9 |
CXR |
X6 |
6 |
|
Oncology visits |
Q 4 mo x 1 y, Q 6 mo x 2 y, Q 12 mo x 2 y |
9 |
|
Dermatology visits |
Q 3 mo x 1 y, Q 4 mo x 1 y, Q 6 mo x 2 y, Q 12 mo x 1 y |
12 |
|
IIA = T2b and T3a |
CMP, LDH |
Each one visit |
11 |
CXR |
x7 |
7 |
|
Oncology visits |
Q 4 mo x 2 y, Q 6 mo x 1 y, Q 12 mo x 2 y |
10 |
|
Dermatology visits |
Q 3 mo x 1 y, Q 4 mo x 1 y, Q 6 mo x 2 y, Q 12 mo x 1 y |
12 |
|
IIB = T3b and T4a |
CMP, LDH, CBC |
Each visit |
11 |
CXR |
x7 |
7 |
|
Oncology visits |
Q 4 mo x 2 y, Q 6 mo x 1 y, Q 12 mo x 2 y |
10 |
|
Dermatology visits |
Q 3 mo x 1 y, Q 4mo x 1 y, Q 6 mo x 3 y |
13 |
|
IIC = T4b |
CMP, LDH, CBC |
Each one visit |
11 |
CXR |
x7 |
7 |
|
Oncology visits |
Q 3 mo x 1 y, Q 4 mo x 1 y, Q 6 mo x 1 y, Q 12 mo x 2 y |
11 |
|
Dermatology visits |
Q 3 mo x 1 y, Q 4mo x 1 y, Q 6 mo x 3 y |
13 |
|
IIIA |
CMP, LDH, CBC |
Each visit |
11 |
CXR |
x7 |
7 |
|
50% CT C/A/P |
Q 12 mo x 5 y |
5 |
|
PET |
x1 |
2 |
|
Oncology visits |
Q 3 mo x 1 y, Q 4 mo x 1 y, Q 6 mo x 1 y, Q 12 mo x 2 y |
11 |
|
Dermatology visits |
Q 3 mo x 1 y, Q 4 mo x 2y, Q 6 mo x 2 y |
14 |
|
IIIB |
CMP, LDH, CBC |
Each visit |
16 |
CXR |
|
8 |
|
50% CT C/A/P |
Q 6 mo x 1 y, Q 12 mo x 4 y |
6 |
|
PET |
x1 |
2 |
|
Oncology visits |
Q 3 mo x 2 y, Q 4 mo x 2 y, Q 6 mo x 1 y |
16 |
|
Dermatology visits |
Q 3 mo x 1 y, Q 4 mo x 2y, Q 6 mo x 2 y |
14 |
|
IIIC |
CMP, LDH, CBC |
Each visit |
16 |
CXR |
|
8 |
|
50% CT C/A/P |
Q 6 mo x 1 y, Q 12 mo x 4 y |
6 |
|
PET |
x1 |
2 |
|
Oncology visits |
Q 3 mo x 2 y, Q 4 mo x 2 y, Q 6 mo x 1 y |
16 |
|
Dermatology visits |
Q 3 mo x 1 y, Q 4 mo x 2y, Q 6 mo x 2 y |
14 |
|
IV |
Active treatment, no surveillance |
|
|
CMP = complete metabolic profile; LDH = lactic dehydrogenase; CBC = complete blood count; CXR = chest x-ray; CT C/A/P = CT chest/abdomen/pelvis; PET = positron emission tomography.